| VLTO |
Report |
Adjusted diluted EPS |
BEAT |
pred ~$1.02 vs. cons $1.008 |
MEDIUM |
| VLTO |
Report |
Total revenue |
IN-LINE |
pred ~$1.462B vs. cons $1.455B |
MEDIUM |
| VLTO |
Report |
Core sales growth |
BEAT |
pred ~3.9% vs. cons 3.54% |
MEDIUM |
| VLTO |
Guide |
Q3 2026 adjusted EPS |
BETTER |
guide ~$1.07-$1.10 vs. cons $1.070 |
MEDIUM |
| VLTO |
Guide |
Q3 2026 core sales growth |
BETTER |
guide ~4.0%-5.0% vs. cons 4.33% |
MEDIUM |
| VLTO |
Guide |
FY 2026 adjusted EPS |
UNCHANGED |
guide ~$4.25-$4.33 vs. cons $4.255 |
MEDIUM |
| VLTO |
Guide |
FY 2026 core sales growth |
BETTER |
guide ~3.5%-4.5% vs. cons 3.91% |
MEDIUM |
| VLTO |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
LOW |
| VLTO |
Return |
5-day cumulative residual |
+0.5% (STABILIZE) |
STABILIZE — modest estimate support offsets a richer pre-print setup |
LOW |